English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/199327
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

A pilot study identifying a set of microRNAs as precise diagnostic biomarkers of acute kidney injury

AuthorsAguado-Fraile, Elia; Ramos, Edurne; Conde, Elisa; Rodríguez, Macarena; Martín-Gómez, Laura; Lietor, Aurora; Candela, Ángel; Ponte, Belen; Liaño, Fernando; García-Bermejo, María Laura
Issue Date16-Jun-2015
PublisherPublic Library of Science
CitationPLoS ONE 10(6): e0127175 (2015)
AbstractIn the last decade, Acute Kidney Injury (AKI) diagnosis and therapy have not notably improved probably due to delay in the diagnosis, among other issues. Precocity and accuracy should be critical parameters in novel AKI biomarker discovery. microRNAs are key regulators of cell responses to many stimuli and they can be secreted to the extracellular environment. Therefore, they can be detected in body fluids and are emerging as novel disease biomarkers. We aimed to identify and validate serum miRNAs useful for AKI diagnosis and management. Using qRT-PCR arrays in serum samples, we determined miRNAs differentially expressed between AKI patients and healthy controls. Statistical and target prediction analysis allowed us to identify a panel of 10 serum miRNAs. This set was further validated, by qRT-PCR, in two independent cohorts of patients with relevant morbi-mortality related to AKI: Intensive Care Units (ICU) and Cardiac Surgery (CS). Statistical correlations with patient clinical parameter were performed. Our results demonstrated that the 10 selected miRNAs (miR-101-3p, miR-127-3p, miR-210-3p, miR-126-3p, miR-26b-5p, miR-29a-3p, miR-146a-5p, miR-27a-3p, miR-93-3p and miR-10a-5p) were diagnostic biomarkers of AKI in ICU patients, exhibiting areas under the curve close to 1 in ROC analysis. Outstandingly, serum miRNAs estimated before CS predicted AKI development later on, thus becoming biomarkers to predict AKI predisposition. Moreover, after surgery, the expression of the miRNAs was modulated days before serum creatinine increased, demonstrating early diagnostic value. In summary, we have identified a set of serum miRNAs as AKI biomarkers useful in clinical practice, since they demonstrate early detection and high diagnostic value and they recognize patients at risk.
Description© 2015 Aguado-Fraile et al.
Publisher version (URL)http://dx.doi.org/10.1371/journal.pone.0127175
URIhttp://hdl.handle.net/10261/199327
DOI10.1371/journal.pone.0127175
E-ISSN1932-6203
Appears in Collections:(IC) Artículos
Files in This Item:
File Description SizeFormat 
Pilot_Aguado_Fraile_Art2015.PDF1,11 MBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.